Suppr超能文献

肾脏对马兜铃酸的转运的生理和分子特征。

Physiological and molecular characterization of aristolochic acid transport by the kidney.

机构信息

Department of Pharmacological Sciences, Stony Brook University, BST-8, 152, Stony Brook, NY 11794, USA.

出版信息

J Pharmacol Exp Ther. 2011 Aug;338(2):588-97. doi: 10.1124/jpet.111.180984. Epub 2011 May 5.

Abstract

Consumption of herbal medicines derived from Aristolochia plants is associated with a progressive tubulointerstitial disease known as aristolochic acid (AA) nephropathy. The nephrotoxin produced naturally by these plants is AA-I, a nitrophenanthrene carboxylic acid that selectively targets the proximal tubule. This nephron segment is prone to toxic injury because of its role in secretory elimination of drugs and other xenobiotics. Here, we characterize the handling of AA-I by membrane transporters involved in renal organic anion transport. Uptake assays in heterologous expression systems identified murine organic anion transporters (mOat1, mOat2, and mOat3) as capable of mediating transport of AA-I. Kinetic analyses showed that all three transporters have an affinity for AA-I in the submicromolar range and thus are likely to operate at toxicologically relevant concentrations in vivo. Structure-activity relationships revealed that the carboxyl group is critical for high-affinity interaction of AA-I with mOat1, mOat2, and mOat3, whereas the nitro group is required only by mOat1. Furthermore, the 8-methoxy group, although essential for toxicity, was not requisite for transport. Mouse renal cortical slices avidly accumulated AA-I, achieving slice-to-medium concentration ratios >10. Uptake by slices was sensitive to known mOat1 and mOat3 substrates and the organic anion transport inhibitor probenecid, which also blocked the production of DNA adducts formed with reactive intracellular metabolites of AA-I. Taken together, these findings indicate that OAT family members mediate high-affinity transport of AA-I and may be involved in the site-selective toxicity and renal elimination of this nephrotoxin.

摘要

食用含有马兜铃酸的草药会导致一种进行性的肾小管间质性疾病,即马兜铃酸(AA)肾病。这些植物自然产生的肾毒素是 AA-I,一种硝基菲羧酸,它选择性地靶向近端肾小管。由于其在药物和其他外源性物质的分泌消除中的作用,这个肾单位部分容易受到毒性损伤。在这里,我们描述了参与肾脏有机阴离子转运的膜转运体对 AA-I 的处理。在异源表达系统中的摄取实验鉴定了鼠源性有机阴离子转运体(mOat1、mOat2 和 mOat3)能够介导 AA-I 的转运。动力学分析表明,这三种转运体对 AA-I 的亲和力均在亚微摩尔范围内,因此在体内可能在与毒性相关的浓度下发挥作用。构效关系研究表明,羧基对于 AA-I 与 mOat1、mOat2 和 mOat3 的高亲和力相互作用至关重要,而硝基仅为 mOat1 所必需。此外,虽然 8-甲氧基基团对于毒性是必需的,但对于转运并非必需。鼠肾皮质切片能够强烈地积累 AA-I,达到切片与培养基浓度比 >10。切片摄取对已知的 mOat1 和 mOat3 底物以及有机阴离子转运抑制剂丙磺舒敏感,丙磺舒也可阻断 AA-I 与反应性细胞内代谢物形成的 DNA 加合物的产生。综上所述,这些发现表明 OAT 家族成员介导 AA-I 的高亲和力转运,可能参与了这种肾毒素的选择性毒性和肾脏消除。

相似文献

7
Western diet exacerbates a murine model of Balkan nephropathy.西方饮食会加重巴尔干肾病的小鼠模型。
Am J Physiol Renal Physiol. 2025 Jan 1;328(1):F15-F28. doi: 10.1152/ajprenal.00185.2024. Epub 2024 Nov 7.

引用本文的文献

5
Overview of aristolochic acid nephropathy: an update.马兜铃酸肾病概述:最新进展
Kidney Res Clin Pract. 2023 Sep;42(5):579-590. doi: 10.23876/j.krcp.22.211. Epub 2023 Jun 15.
6
ATP/ADP biosensor organoids for drug nephrotoxicity assessment.用于药物肾毒性评估的ATP/ADP生物传感器类器官
Front Cell Dev Biol. 2023 Mar 2;11:1138504. doi: 10.3389/fcell.2023.1138504. eCollection 2023.
7
Pathological consequences of DNA damage in the kidney.肾脏中DNA损伤的病理后果。
Nat Rev Nephrol. 2023 Apr;19(4):229-243. doi: 10.1038/s41581-022-00671-z. Epub 2023 Jan 26.
9
Aristolochic acid I exposure decreases oocyte quality.马兜铃酸I暴露会降低卵母细胞质量。
Front Cell Dev Biol. 2022 Aug 11;10:838992. doi: 10.3389/fcell.2022.838992. eCollection 2022.

本文引用的文献

2
Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse.细胞色素 P450 1A2 可解毒小鼠体内的马兜铃酸。
Drug Metab Dispos. 2010 May;38(5):761-8. doi: 10.1124/dmd.110.032201. Epub 2010 Feb 17.
7
Aristolochic acid nephropathy: a worldwide problem.马兜铃酸肾病:一个全球性问题。
Kidney Int. 2008 Jul;74(2):158-69. doi: 10.1038/ki.2008.129. Epub 2008 Apr 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验